Neurolign Revenue and Competitors
Estimated Revenue & Valuation
- Neurolign's estimated annual revenue is currently $1.1M per year.
- Neurolign's estimated revenue per employee is $84,000
Employee Data
- Neurolign has 13 Employees.
- Neurolign grew their employee count by 8% last year.
Neurolign's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Marketing | Reveal Email/Phone |
2 | Director, Operations | Reveal Email/Phone |
3 | Chief Development Officer | Reveal Email/Phone |
4 | Senior Software/Neuroengineer | Reveal Email/Phone |
5 | iOS Developer + Team Lead | Reveal Email/Phone |
Neurolign Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $106.5M | 599 | -17% | $2.3M | N/A |
#2 | $0.2M | 3 | N/A | N/A | N/A |
#3 | $100.3M | 0 | N/A | $293.4M | N/A |
#4 | $1.5M | 18 | 20% | N/A | N/A |
#5 | $454.3M | 2269 | 3% | $230M | N/A |
#6 | $1.3M | 15 | -32% | N/A | N/A |
#7 | $7.1M | 56 | -2% | N/A | N/A |
#8 | $8.3M | 66 | 5% | N/A | N/A |
#9 | $1.1M | 13 | N/A | N/A | N/A |
#10 | $29.3M | 190 | N/A | N/A | N/A |
What Is Neurolign?
Neurolign is a privately held diagnostic and pharmaceutical company focused on bringing superior diagnostic solutions and novel therapeutics for the diagnosis and treatment of neurological conditions to physicians and their patients. Neurolign's founder is Eugene Melnyk, the creator of multiple healthcare companies, including Biovail Corporation (acquired by Bausch Health), and the current owner of the Ottawa Senators Hockey Club.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$1.1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 13 | -7% | $3M |
#2 | $1.1M | 13 | N/A | N/A |
#3 | $0.9M | 13 | N/A | N/A |
#4 | $2M | 13 | 0% | N/A |
#5 | $1.9M | 13 | -7% | N/A |